Microneedle Flu Vaccine Market, by Product Type (Solid Microneedle, Hollow Microneedle , Coated Microneedle, Dissolving Microneedle), by Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine), by Flu Type (Influenza A( H1N1, H3N1), Influenza B) an

Microneedle Flu Vaccine Market, by Product Type (Solid Microneedle, Hollow Microneedle , Coated Microneedle, Dissolving Microneedle), by Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine), by Flu Type (Influenza A( H1N1, H3N1), Influenza B) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Drug delivery through the skin by transdermal patches has always been effective against viral infection and flu. Drug delivery through transdermal route is mainly effective due to passive diffusion of the drug and followed by drug development in transdermal delivery systems through different mechanism of action such as iontophorresis and sonophoresis. Moreover, pharmaceutical companies are focusing on development of micro-needle vaccines due to its immense utility in transdermal delivery of very large drug molecules with ionic and hydrophilic nature.
Market Dynamics
The global micro-needle flu vaccine market is expected to witness significant growth during the forecast period, as government agencies are investing more on the research and development of microneedle vaccine patches. For instance, in August 2020, Verndari, Inc received the funding of US$ 1 million from the U.S. Government Agency BARDA for accelerating the research and development of VaxiPatch, a dermal patch vaccine technology that can be used for treatment of various infectious diseases such as influenza flu.
Key features of the study:
This report studies the current scenario as well as the future potential for the global microneedle flu vaccine market. The market for microneedle flu vaccine is segmented on basis of product type, vaccine type, flu type and region.
This report provides in-depth analysis of the global microneedle flu vaccine market and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategy adopted by the leading players.
It profiles leading players in the global microneedle flu vaccine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
The global microneedle flu vaccine market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the global microneedle flu vaccine market.
Detailed Segmentation:
Global Microneedle Flu Vaccine Market, By Product Type:
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
Global Microneedle Flu Vaccine Market, By Vaccine Type:
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
Global Microneedle Flu Vaccine Market, By Flu Type:
Influenza A
H1N1
H3N1
Influenza B
Global Microneedle Flu Vaccine Market, By Region:
North America
By Product Type:
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
By Vaccine Type:
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
By Virus Type:
Influenza A
H1N1
H3N1
Influenza B
By Country:
U.S.
Canada
Latin America
By Product Type:
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
By Vaccine Type:
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
By Virus Type:
Influenza A
H1N1
H3N1
Influenza B
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
By Vaccine Type:
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
By Virus Type:
Influenza A
H1N1
H3N1
Influenza B
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
By Vaccine Type:
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
By Virus Type:
Influenza A
H1N1
H3N1
Influenza B
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
By Vaccine Type:
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
By Virus Type:
Influenza A
H1N1
H3N1
Influenza B
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
By Vaccine Type:
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
By Virus Type:
Influenza A
H1N1
H3N1
Influenza B
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Vaccine Companies:
Sanofi S.A.*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
GC Pharma
Microneedle Companies:
Debiotech S.A*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
3M Company
NanoPass Technologies Limited
Corium International, Inc
Becton, Dickinson and Company
FluGen, Inc.
CosMED Pharmaceuticals Co., Ltd.
Microdermics
OraSure Technologies, Inc.
“*” marked represents similar segmentation in other categories in the respective section.